过敏高风险儿童在医院监督下接种疫苗的安全性:一项9年研究
一项单中心回顾性研究纳入2016年7月至2025年5月因过敏风险转诊接种的180名儿童,共接种368剂疫苗。结果显示监督接种期间无过敏反应或严重全身反应发生,仅5名儿童(2.8%)出现轻微自限性反应。转诊时许多儿童免疫规划延迟,强制疫苗不依从率为28.9%,从处方到监督接种的中位延迟为115天。
要点
- 过敏高风险儿童在医院监督下全剂量接种疫苗未发生过敏反应或严重全身反应。
- 仅2.8%儿童出现轻微自限性反应,占接种访视的1.4%。
- 转诊时强制疫苗不依从率28.9%,处方至接种中位延迟115天。
核心结论
- 对于被认为存在超敏反应风险的儿童,包括有过敏反应史的儿童,在医院监督下接种疫苗是安全的。
研究设计与样本
- 回顾性单中心研究,纳入2016年7月至2025年5月转诊至过敏专科医生监督下接种疫苗的儿童,共180名,接种368剂疫苗。
主要发现
- 监督接种期间无过敏反应或严重全身反应病例发生。
- 5名儿童(2.8%)出现轻微自限性反应,占接种访视的1.4%。
- 转诊时许多儿童免疫规划延迟或不完整;强制疫苗不依从率为28.9%,强制加推荐疫苗不依从率为47.2%。
- 从疫苗处方到监督接种的中位延迟为115天。
关键数值与推荐
- 疫苗在医院环境下以全剂量接种,并设定了预先定义的接种后观察期。
- 即时和延迟不良反应采用标准化标准记录。
- 接种状态和延迟情况参照国家适龄免疫规划评估。
临床怎么用
- 由过敏专科医生主导的结构化方案,结合个体化风险评估、标准剂量接种和适当观察,可能促进延迟的免疫规划完成,并有助于解决过敏儿童群体的疫苗犹豫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Fear of allergic reactions is a frequent cause of vaccine hesitancy among families of children with allergic diseases. Vaccination in a supervised hospital setting is often recommended for children considered at increased risk of hypersensitivity. However, real-world data on the safety and impact of this approach in pediatric populations remain limited. METHODS: We performed a retrospective, single-center study including children referred for vaccination under allergist supervision between July 2016 and May 2025. Vaccines were administered at full dose in a hospital setting, with predefined post-vaccination observation periods. Immediate and delayed adverse reactions were recorded using standardized criteria. Vaccination status and delays were assessed in relation to national age-appropriate immunization schedules. RESULTS: A total of 180 children received 368 vaccine doses. Mean age was 4.2 years, and 62.2% were male. The main reasons for referral were food allergy and previous adverse events following immunization. Thirty-one children (17.2%) had a history of anaphylaxis, predominantly food-related. No cases of anaphylaxis or severe systemic reactions occurred during supervised vaccination. Mild, self-limited reactions were observed in five children (2.8%), accounting for 1.4% of vaccination visits. At referral, many children had delayed or incomplete immunization schedules. At the time of review, non-compliance was 28.9% for mandatory vaccines and 47.2% when mandatory plus recommended vaccines were considered; the median delay between vaccine prescription and supervised administration was 115 days. CONCLUSION: Supervised hospital-based vaccination is safe in children perceived to be at risk of hypersensitivity reactions, including those with previous anaphylaxis. A structured, allergist-led approach combining individualized risk assessment, standard-dose administration, and appropriate observation may facilitate completion of delayed immunization schedules and may help address vaccine hesitancy in allergic pediatric populations.
引用
- Donesana M, Marseglia A, Laterza L, et al. Safety of supervised hospital vaccination in children at risk of hypersensitivity: A 9-year study. Vaccine. 2026. PMID: 42105395. doi:10.1016/j.vaccine.2026.128663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。